198 related articles for article (PubMed ID: 22916174)
1. Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review.
Xie F; Zhang X; Li H; Zheng T; Xu F; Shen R; Yan L; Yang J; He J
PLoS One; 2012; 7(8):e42879. PubMed ID: 22916174
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
Zhao H; Zheng M; Wang K; Wang L; He H; Wang M; Shi Y; Huang S; Ji F; Li X; Zhu H; Wang L; Zhang X; Shi X; Zhao S; Fu B; Wu T
J Cancer Res Ther; 2018; 14(4):807-814. PubMed ID: 29970657
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis.
Cao J; Kong FH; Liu X; Wang XB
World J Gastroenterol; 2019 Jul; 25(27):3649-3663. PubMed ID: 31367163
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone.
Kawata A; Une Y; Hosokawa M; Wakizaka Y; Namieno T; Uchino J; Kobayashi H
Am J Clin Oncol; 1995 Jun; 18(3):257-62. PubMed ID: 7747715
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis.
Li YC; Zhao L; Wu JP; Qu CX; Song QK; Wang RB
Cytotherapy; 2016 Dec; 18(12):1525-1531. PubMed ID: 27746013
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis.
Wang H; Liu A; Bo W; Feng X; Hu Y; Tian L; Zhang H; Tang X
Dig Liver Dis; 2016 Nov; 48(11):1275-1282. PubMed ID: 27481586
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
[TBL] [Abstract][Full Text] [Related]
8. The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis.
Wang J; Shen T; Wang Q; Zhang T; Li L; Wang Y; Fang Y
Immunotherapy; 2019 Oct; 11(15):1325-1335. PubMed ID: 31578914
[No Abstract] [Full Text] [Related]
9. Prevention of hepatocellular carcinoma recurrence: actuality and perspectives.
Takayama T; Makuuchi M
Hepatogastroenterology; 2002; 49(43):87-90. PubMed ID: 11941990
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
[TBL] [Abstract][Full Text] [Related]
11. Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review.
Yuan BH; Li RH; Yuan WP; Yang T; Tong TJ; Peng NF; Li LQ; Zhong JH
Oncotarget; 2017 Mar; 8(11):18537-18549. PubMed ID: 28061472
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
[TBL] [Abstract][Full Text] [Related]
15. [Studies on lymphokine-activated killer (LAK) cell: accumulation in tumor tissue and the therapeutic effects of adoptive immunotherapy].
Wakizaka Y
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):475-87. PubMed ID: 1330859
[TBL] [Abstract][Full Text] [Related]
16. Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis.
Chen C; Ma YH; Zhang YT; Zhang F; Zhou N; Wang X; Liu T; Li YM
Cytotherapy; 2018 Aug; 20(8):975-989. PubMed ID: 30072299
[TBL] [Abstract][Full Text] [Related]
17. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.
Zhong JH; Ma L; Wu LC; Zhao W; Yuan WP; Wu FX; Zhang ZM; Huang S; You XM; Li LQ
Int J Clin Pract; 2012 Jan; 66(1):21-7. PubMed ID: 22171902
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy].
Takayama T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():683-7. PubMed ID: 11762037
[No Abstract] [Full Text] [Related]
19. [Lymphokine-activated killer cell adoptive immunotherapy for cancer treatment and its significance].
Toge T; Yamaguchi Y
Hum Cell; 1992 Sep; 5(3):218-25. PubMed ID: 1334695
[TBL] [Abstract][Full Text] [Related]
20. Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
Mo HY; Liao YY; You XM; Cucchetti A; Yuan BH; Li RH; Zhong JH; Li LQ
PLoS One; 2017; 12(3):e0174222. PubMed ID: 28339493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
